CBD and EGCG (from green tea) showed complementary antiviral effects against SARS-CoV-2 — CBD reduced ACE2 expression while EGCG suppressed spike protein, together blocking virus at multiple stages.
Antiviral researchers, natural product scientists, and anyone interested in CBD's potential applications beyond pain and anxiety.
What the researchers found
CBD decreased ACE2 receptor expression (virus entry point), while EGCG suppressed spike protein expression. Combined, they complement each other to inhibit SARS-CoV-2 at multiple levels — entry, protein expression, and reinvasion — while minimizing adverse effects of ACE2 changes.
Why it matters
Finding natural compounds that work together against coronaviruses through complementary mechanisms provides a framework for developing combination antiviral strategies using safe, accessible compounds.
The numbers in context
CBD and tea polyphenols showed inhibitory effects comparable to chloroquine (positive control). EGCG identified 11 spike protein-interacting proteins significantly affected. Transcriptome analysis showed overlapping and distinct gene regulation pathways.
How the study worked
In vitro study testing CBD, green tea polyphenols, EGCG, and theaflavin against SARS-CoV-2, using co-immunoprecipitation mass spectrometry, transcriptome analysis, and functional pathway enrichment.
What this study cannot tell us
In vitro study only — tissue concentrations achievable in humans may be insufficient. COVID-19 landscape has evolved significantly since study conception. Viral variants may respond differently.
How to read the evidence
Thorough in vitro investigation with transcriptomic analysis, but lacks animal model validation and clinical relevance remains uncertain.
When this study was published
Recent study exploring natural compound combinations against SARS-CoV-2, contributing to ongoing antiviral research.
The bigger picture
The COVID-19 pandemic highlighted the need for diverse antiviral strategies. Natural compounds like CBD and EGCG offer multi-target mechanisms that may be harder for viruses to develop resistance against compared to single-target drugs.
Questions still open
- Could CBD/EGCG combinations be effective as prophylactic supplements? Would these compounds show activity against other coronaviruses or respiratory viruses?
Common questions
Can CBD prevent COVID-19?
Why combine CBD with green tea compounds?
Read the original research
Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.
Virology, 610, 110579
Citation
Zhang, Meng-Chun; Wu, Hao; Wang, Jiaxing; Lu, Meixi; Cao, Danli; Lin, Jingwen; Chen, Hang; Lin, Caiji; Wang, Yao; Zhang, Xing-Hua; Xu, Mengzhi; Liu, Gui-Rong; Li, Han; Wang, Pengfei; Wang, Xiaoyu; Xu, Xiaohui; Liu, Shu-Lin; Liu, Huidi. (2025). Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.. Virology, 610, 110579. https://doi.org/10.1016/j.virol.2025.110579
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk